Mutations of EGFR are common drivers of oncogenesis in NSCLC, among which exon 19 deletions (ex19del) and exon 21 L858R point mutations (L858R) are the most common EGFR alterations.19 This evidence concerns the gene EGFR and non-small cell lung carcinoma.